Category: Drug Development
Drug Development market research reports by DelveInsight
-
PD-1 and PD-L1 inhibitors - Pipeline Insight, 2022
“ PD-1 and PD-L1 inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in PD-1 and PD-L1 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therap ... Read More
-
P38 mitogen-activated protein (MAP) kinase inhibitors - Pipeline Insight, 2022
“ P38 mitogen-activated protein (MAP) kinase inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in P38 mitogen-activated protein (MAP) kinase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and ... Read More
-
Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022
“ Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Hematopoietic progenitor kinase 1 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
TrkC receptor antagonists - Pipeline Insight, 2022
“ TrkC receptor antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in TrkC receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2022
“ Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Trk (TrkB) receptor antagonists - Pipeline Insight, 2022
“ Trk (TrkB) receptor antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Trk (TrkB) receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
-
HER2Negative Metastatic Breast Cancer - Epidemiology Forecast to 2032
DelveInsight's "" HER2Negative Metastatic Breast Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted HER2Negative Metastatic Breast Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, a ... Read More
-
5-HT2A Agonists - Pipeline Insight, 2022
“ 5-HT2A Agonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in 5-HT2A Agonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by p ... Read More
-
DUX4 protein inhibitors - Pipeline Insight, 2022
“ DUX4 protein inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in DUX4 protein inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
WEE1 protein inhibitors - Pipeline Insight, 2022
“ WEE1 protein inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in WEE1 protein inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
MPYS protein stimulants - Pipeline Insight, 2022
“ MPYS protein stimulants - Pipeline Insight, 2022 ” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in MPYS protein stimulants pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeuti ... Read More
-
HIV integrase inhibitors - Pipeline Insight, 2022
“ HIV integrase inhibitors - Pipeline Insight, 2021 ,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in HIV integrase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeut ... Read More
-
Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032
DelveInsight's "" Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene and Cell Therapies targeting CNS disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spa ... Read More
-
Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022
“ Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 7+ companies and 8+ pipeline drugs in Protein tyrosine phosphatase non receptor type 11 antagonists pipeline landscape. It covers the pipeline drug profiles, includ ... Read More
Research Assistance
